Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research
<p>Abstract</p> <p>Background</p> <p>There is conflicting information as to whether antiretroviral drugs with better central nervous system (CNS) penetration (neuroHAART) assist in improving neurocognitive function and suppressing cerebrospinal fluid (CSF) HIV RNA. The...
Main Authors: | Cysique Lucette A, Waters Edward K, Brew Bruce J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-11-01
|
Series: | BMC Neurology |
Online Access: | http://www.biomedcentral.com/1471-2377/11/148 |
Similar Items
-
Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study
by: Maruff Paul, et al.
Published: (2006-12-01) -
In vitro models as surrogates of in vivo antiretroviral efficacy in central nervous system of HIV-1 infected subjects
by: Mora Peris, Borja
Published: (2016) -
Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity.
by: Chloe Gott, et al.
Published: (2017-01-01) -
Nanoparticle-based drug delivery to improve the efficacy of antiretroviral therapy in the central nervous system
by: Gomes MJ, et al.
Published: (2014-04-01) -
Central Nervous System Strongyloidiasis and Cryptococcosis in an HIV-Infected Patient Starting Antiretroviral Therapy
by: Mónica Rodríguez, et al.
Published: (2012-01-01)